FDA shortens interval for Moderna booster dose
The United States Food and Drug Administration (FDA) said on Friday that it shortened the interval after which people can receive the booster dose of Moderna’s COVID-19 shot.
The FDA noted that all those aged over 18 will be able to receive their booster shot at least five months after getting their second dose.
In November, Moderna’s booster was approved for all adults at least six months after their second dose.
Get involved!
Comments